Pharmacovigilance support with regional scope for laboratories marketing products in multiple Latin American countries.
The Good Pharmacovigilance Practices Program is designed as a quality system based on national and international guidelines, covering the detection, evaluation, validation, follow-up, reporting and filing of adverse events of products during their commercialization.
For laboratories with a presence or commercial operations in more than one Latin American country, FP Clinical Pharma supports Pharmacovigilance management by addressing the specific requirements of each market, coordinating communication between headquarters, local distributors and health authorities.
If your laboratory needs Pharmacovigilance coverage in more than one country in the region, write to us and we will coordinate a tailored service based on the markets where you operate.
Good Pharmacovigilance Practices program under ANMAT regulations.
View detailsConducting Clinical Research studies from Phase I to IV with the highest quality standards.
View detailsDesign, execution and analysis of bioavailability, bioequivalence and pharmacokinetic studies.
View details